(2S)-2-(((2-(benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid,
L-phenylalanine, n-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-,
lifitegrast,
SAR 1118,
SAR-1118,
SHP-606,
SHP606,
Xiidra,
Lifitegrast,
Xiidra,
1025967-78-5,
SAR-1118,
SAR 1118,
UNII-038E5L962W,
CHEMBL2048028,
SAR1118,
038E5L962W,
(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid,
(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic acid,
L-Phenylalanine, N-((2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl)-3-(methylsulfonyl)-,
Lifitegrast [USAN:INN],
L-Phenylalanine, N-[[2-(6-benzofuranylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl]carbonyl]-3-(methylsulfonyl)-,
Xiidra (TN),
Lifitegrast (USAN/INN),
Lifitegrast; SAR 1118,
GTPL7533,
SCHEMBL2632068,
DTXSID60145345,
CHEBI:133023,
EX-A2582,
BDBM50386331,
MFCD28502439,
ZINC84668739,
AKOS030628489,
CS-6264,
DB11611,
SB18920,
compound 1g [PMID: 24900456],
(2S)-2-(((2-(Benzofuran-6-ylcarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinolin-6- yl)carbonyl)amino)-3-(3-(methylsulfonyl)phenyl)propanoic acid,
DS-20052,
HY-19344,
D10374,
(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid,
N-[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carbonyl]-3-(methanesulfonyl)-L-phenylalanine,
D04ISS,
D0Q9EV,
SHP606,
SPD606,
Umbelliferone-3-carboxylic acid,
SAR-1119,
CID11965427,
CID 11965427,
Dual LFA-1/ICAM-1 inhibitors, Sunesis,
SAR 1118-023,
SAR-1118-023,
Dual LFA-1/ICAM-1 inhibitors (inflammatory diseases), SARcode,
Dual leukocytefunction-associated antigen-1/intracellular adhesion molecule-1 inhibitors (inflammatory diseases), SARcode,